Nevada 2025 Regular Session

Nevada Senate Bill SB228

Introduced
2/20/25  
Refer
2/20/25  

Caption

Appropriates money to establish a Pediatric Stem Cell and Bone Marrow Transplant Program. (BDR S-124)

Impact

In terms of its impact on state laws, SB228 includes provisions that require the Cure 4 The Kids Foundation to report to the Interim Finance Committee regarding the expenditures of these funds. As it stands, the bill does not indicate any direct changes to existing laws but introduces a new program focused on pediatric healthcare, potentially filling a critical gap in treatment options for children suffering from life-threatening diseases requiring stem cell or bone marrow transplants. This bill may lead to enhanced medical capabilities within the state and potentially attract families seeking such specialized care.

Summary

Senate Bill 228 seeks to establish a Pediatric Stem Cell and Bone Marrow Transplant Program in Nevada, specifically appropriating a total of $9.5 million for its implementation. The allocated funds are aimed at developing the necessary infrastructure, acquiring equipment, and covering the costs associated with performing the initial five bone marrow transplant operations. The bill also mandates reports and audits to ensure accountability on how the appropriated funds are utilized, stipulating that the Cure 4 The Kids Foundation will oversee the program's establishment and management.

Sentiment

The sentiment surrounding SB228 appears to be largely positive, especially among advocates for pediatric healthcare and medical advancements. Supporters argue that this initiative is crucial for providing necessary treatments to children within the state, thereby improving health outcomes. Nonetheless, there might be concerns regarding funding allocation and the program's effectiveness, which could lead to debates around prioritization of healthcare spending in Nevada's budget.

Contention

One notable point of contention may arise from the program's funding—specifically, whether such an allocation is sustainable or adequate over time. Stakeholders might question if a one-time appropriation will be sufficient to cover ongoing operational costs beyond the initial funding period, prompting discussions on how to support the program long-term. Additionally, while the bill supports healthcare advancements, there may be apprehensions regarding the prioritization of funds, especially when compared to other pressing healthcare needs in the state.

Companion Bills

No companion bills found.

Previously Filed As

NV SB00439

An Act Requiring Medicaid Coverage For Bone Marrow And Stem Cell Transplants And Fda-approved Gene Therapies To Treat Sickle Cell Disease.

NV A05122

Allows for individuals to consent to receive information from the C.W. Bill Young Cell Transplantation Program and the national marrow donor program at the time of application for or renewal of a driver's license or non-driver identification card; directs the commissioner of motor vehicles to establish a process by which the department of motor vehicles shall refer driver's license and non-driver identification card applicants who consent to having their information shared with the C.W. Bill Young Cell Transplantation Program and the national marrow donor program for the purposes of receiving information from such programs about enrolling as a potential donor.

NV S03335

Allows for individuals consent to receive information from the C.W. Bill Young Cell Transplantation Program and the national marrow donor program at the time of application for or renewal of a driver's license or non-driver identification card; directs the commissioner of motor vehicles to establish a process by which the department of motor vehicles shall refer driver's license and non-driver identification card applicants who consent to having their information shared with the C.W. Bill Young Cell Transplantation Program and the national marrow donor program for the purposes of receiving information from such programs about enrolling as a potential donor.

NV HB1242

Providing for public health notification programs; and establishing a bone marrow donor recruitment program.

NV S0829

Provides temporary caregivers benefits to any eligible bone marrow transplant donor or living organ donor and would provide definitions for both

NV SB1214

Stem cells; regenerative therapy

NV HB5626

Relating to the right of an employee to unpaid leave to donate an organ or bone marrow or to receive an organ or bone marrow transplant.

NV S1768

Stem Cell Therapy

NV H1617

Stem Cell Therapy

NV HF1146

Minnesota SNAP step up for seniors program established, and money appropriated.

Similar Bills

MD HB390

Budget Bill (Fiscal Year 2027)

MD SB282

Budget Bill (Fiscal Year 2027)

MD HB350

Budget Bill (Fiscal Year 2026)

MD SB319

Budget Bill (Fiscal Year 2026)

PA HB1330

To provide appropriations from the General Fund for the expenses of certain agencies of the Executive Department for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills incurred and remaining unpaid at the close of the fiscal year ending June 30, 2025.

PA SB160

To provide appropriations from the General Fund for the expenses of the Executive, Legislative and Judicial Departments of the Commonwealth, the public debt and the public schools for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills incurred and remaining unpaid at the close of the fiscal year ending June 30, 2025; to provide appropriations from special funds and accounts to the Executive and Judicial Departments for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills remaining unpaid at the close of the fiscal year ending June 30, 2025; to provide for the appropriation of Federal funds to the Executive and Judicial Departments for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills remaining unpaid at the close of the fiscal year ending June 30, 2025; and to provide for the additional appropriation of Federal and State funds to the Executive and Legislative Departments for the fiscal year July 1, 2024, to June 30, 2025, and for the payment of bills incurred and remaining unpaid at the close of the fiscal year ending June 30, 2024.

PA SB280

To provide appropriations from the General Fund for the expenses of the Executive, Legislative and Judicial Departments of the Commonwealth, the public debt and the public schools for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills incurred and remaining unpaid at the close of the fiscal year ending June 30, 2025; to provide appropriations from special funds and accounts to the Executive and Judicial Departments for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills remaining unpaid at the close of the fiscal year ending June 30, 2025; to provide for the appropriation of Federal funds to the Executive and Judicial Departments for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills remaining unpaid at the close of the fiscal year ending June 30, 2025; and to provide for the additional appropriation of Federal and State funds to the Executive and Legislative Departments for the fiscal year July 1, 2024, to June 30, 2025, and for the payment of bills incurred and remaining unpaid at the close of the fiscal year ending June 30, 2024.

PA SB1161

To provide appropriations from the General Fund for the expenses of the Executive, Legislative and Judicial Departments of the Commonwealth, the public debt and the public schools for the fiscal year July 1, 2026, to June 30, 2027, and for the payment of bills incurred and remaining unpaid at the close of the fiscal year ending June 30, 2026; to provide appropriations from special funds and accounts to the Executive and Judicial Departments for the fiscal year July 1, 2026, to June 30, 2027, and for the payment of bills remaining unpaid at the close of the fiscal year ending June 30, 2026; to provide for the appropriation of Federal funds to the Executive and Judicial Departments for the fiscal year July 1, 2026, to June 30, 2027, and for the payment of bills remaining unpaid at the close of the fiscal year ending June 30, 2026; and to provide for the additional appropriation of Federal and State funds to the Executive and Legislative Departments for the fiscal year July 1, 2025, to June 30, 2026, and for the payment of bills incurred and remaining unpaid at the close of the fiscal year ending June 30, 2025.